No increase in prices of essential drugs: Govt

Prices of 44 drugs, 108 formulations have actually come down, says Chemicals and Fertiliser Minister Ananth Kumar

Press Trust of India New Delhi
Last Updated : Nov 28 2014 | 3:05 PM IST
Refuting Opposition's contention, the government today said there had been no increase in the prices of essential drugs in the last six months.

Prices of 44 drugs and 108 formulations have actually come down during the period, Chemicals and Fertiliser Minister Ananth Kumar said in Rajya Sabha.

He refuted suggestions that price of some drugs used to treat tuberculosis, AIDS, diabetes and heart ailments were on the rise following decontrolling of these drugs.

National Pharmaceutical Pricing Authority (NPPA), he said, through a notification in July had capped the maximum retail price of 108 non-scheduled single ingredient drug formulations related to treatment for diabetes and cardiovascular diseases.

"Out of 108 medicines, only two notifications were withdrawn because they were already covered as scheduled medicines. A large number of manufacturers have already implemented the price reduction," he said.

To a question on the price of anti-cancer tablet G
 
livec, he said, as per the price list in Form V of the DPCO, 2013, the medicine is sold at Rs 8,452.38 for 30 tablets, which is in conformity with the ceiling price notified for this drug formulation.

Kumar said according to WHO Global TB Report, 2014, the estimated number of TB patients in India in the year 2013 was 2.6 million.

He informed the House that a total number of HIV/AIDS (PLHIV) registered in active care at Anti-Retroviral Therapy Centres across the country are 10.98 lakh.

"However, it is estimated that there are around 20.88 lakh people infected in India as per HIV estimation of 2011," he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 28 2014 | 2:41 PM IST

Next Story